Astaxanthin attenuates the UVB-induced secretion of prostaglandin E 2 and interleukin-8 in human keratinocytes by interrupting MSK1 phosphorylation in a ROS depletion-independent manner

Experimental Dermatology

Volumn 21, Issue SUPPL.1, 2012, Pages 11-17

  Terazawa, Shuko ^a   Nakajima, Hiroaki ^a   Shingo, Mori ^a   Niwano, Takao ^a   Imokawa, Genji ^a  

^a TOKYO UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

Astaxanthin; Human keratinocytes; Interleukin 8; Mitogen and stress activated kinase 1; Prostaglandin E 2; UVB

Indexed keywords

ASTAXANTHIN; CYCLOOXYGENASE 2; I KAPPA B; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE P38; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOTAGMIN I;

ARTICLE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ULTRAVIOLET B RADIATION;

CYCLOOXYGENASE 2; DINOPROSTONE; DOWN-REGULATION; ENZYME INHIBITORS; HUMANS; INTERLEUKIN-8; ISOQUINOLINES; KERATINOCYTES; MICROSCOPY, CONFOCAL; MODELS, BIOLOGICAL; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; SULFONAMIDES; ULTRAVIOLET RAYS; XANTHOPHYLLS;

EID: 84861469110     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2012.01496.x     Document Type: Article

References (49)

1. Yoon J H, Lim T G, Lee K M et al. J Agric Food Chem 2010: 59: 222-228.
2. Rhodes L E, Belgi G, Parslew R et al. J Invest Dermatol 2001: 117: 880-885.
3. Black A K, Greaves M W, Hensby C N et al. Br J Clin Pharmacol 1978: 5: 431-436.
4. Warren J B. FASEB J 1994: 8: 247-251.
5. Strickland I, Rhodes L E, Flanagan B F et al. J Invest Dermatol 1997: 105: 763-768.
6. Matsuzawa A, Ichijo H. Biochim Biophys Acta 2008: 1780: 1325-1336.
7. Saitoh M, Nishitoh H, Fujii M et al. EMBO J 1998: 17: 2596-2606.
8. Kamata H, Honda S, Maeda S et al. Cell 2005: 120: 649-661.
9. Pham C G, Bubici C, Zazzeribu F et al. Cell 2004: 119: 529-542.
10. Goldman E H, Chen L, Fu H. J Biol Chem 2004: 279: 10442-10449.
11. Shimidzu N F. Fish Sci 1996: 62: 134-137.
12. Miki W. Pure Appl Chem 1991: 63: 141-146.
13. Krinsky N I. Free Radic Biol Med 1989: 7: 617-635.
14. Lee S J, Bai S K, Lee K S et al. Mol Cell 2003: 16: 97-105.
15. Suzuki Y, Ohgami K, Shiratori K et al. Exp Eye Res 2006: 82: 275-281.
16. Kim Y H, Koh H K, Kim D S. Int Immunopharmacol 2010: 12: 1560-1572.
17. Suganuma K, Nakajima H, Otsuki M et al. J Dermatol Sci 2010: 58: 136-142.
18. Lee J, Jung E, Lee J et al. Life Sci 2006: 79: 2480-2485.
19. Mosmann T. J Immunol Methods 1983: 65: 55-63.
20. Nakajima H, Wakabayashi Y, Wakamatsu K et al. Arch Dermatol Res 2011: 303: 263-276.
21. Chen W, Tang Q, Gonzales M S et al. Oncogene 2001: 20: 3921-3926.
22. Fernau N S, Fugmann D, Leyendecker M et al. J Biol Chem 2010: 285: 3896-3904.
23. Sur R, Babad J M, Garay M et al. J Invest Dermatol 2008: 128: 336-344.
24. He G, Sung Y M, Fischer S M. Prostaglandins Leukot Essent Fatty Acids 2006: 74: 193-197.
25. Kim H J, Kim T Y. J Invest Dermatol 2004: 123: 547-555.
26. Lee H J, Lee J, Lee S K et al. BMC Cancer 2007: 7: 176.
27. Dai X, Yamasaki K, Shirakata Y et al. J Invest Dermatol 2004: 123: 1078-1085.
28. Kang J S, Kim H N, Jung D J et al. J Invest Dermatol 2007: 127: 698-706.
29. Grandjean-Laquerriere A, Le Naour R, Gangloff S C et al. Cytokine 2005: 29: 197-207.
30. Hura S, Lee Y S, Yooa H et al. J Dermatol Sci 2010: 59: 163-169.
31. Lee A K, Sung S H, Kim Y C et al. Br J Pharmacol 2003: 139: 11-20.
32. Afaq F, Adhami V M, Ahmad N et al. Oncogene 2003: 22: 1035-1044.
33. Vicentini F Y, He T, Shao Y et al. J Dermatol Sci 2011: 61: 162-168.
34. Adhami V M, Afaq F, Ahmad N. Neoplasia 2003: 5: 74-82.
35. Vermeulen L, De Wilde G, Van Damme P. EMBO J 2003: 22: 1313-1324.
36. Zhong H, Voll R E, Ghosh S. Mol Cell 1998: 1: 661-671.
37. Reber L, Vermeulen L, Haegeman G. PLoS ONE 2009: 4: e4393.
38. Sakurai H, Chiba H, Miyoshi H et al. J Biol Chem 1999: 274: 30353-30356.
39. Deak M, Clifton A D, Lucocq L M et al. EMBO J 1998: 17: 4426-4441.
40. McCoy C E, Campbell D G, Deak M et al. Biochem J 2005: 387: 507-517.
41. Wiggin G R, Soloaga A, Foster J M et al. Mol Cell Biol 2002: 22: 2871-2881.
42. McCoy C E, Macdonald A, Morrice N A et al. Biochem J 2007: 402: 491-501.
43. New L, Zhao M, Li Y et al. Biol Chem 1999: 274: 1026-1032.
44. Cheresternsen C A, Sturgill T W. J Biol Chem 2002: 277: 27733-27741.
45. Gesser B, Johansen C, Rasmussen M K et al. J Invest Dermatol 2007: 127: 2129-2137.
46. Ockenfels H M, Schultewolter T, Ockenfels G et al. Br J Dermatol 1998: 139: 390-395.
47. Funding A T, Johansen C, Kragballe K et al. J Invest Dermatol 2006: 126: 1784-1791.
48. Spencer S R, Wilczak C A, Talalay P. Cancer Res 1990: 50: 7871-7875.
49. Perl A, Gergely P Jr, Puskas F et al. Antioxid Redox Signal 2002: 4: 427-443.